According to Silvu itsecu (source: The Australian, july 19), they had been discussing with tasly group for about 9 months. And all we know, we always see the disclosures from MSB that they have been in discussion with potential partners , and we were so used to hearing that , at one point most of the shareholders had doubt about the validity and credibility of that statement . But now that doubt is cleared. Silvu itsecu also mentioned that it has opened door for other products candidates. Focus and right management are the terms we can associate with MSB right now. Now, management can focus on commercial deal rather than cap raise. No wonder why, kite pharma commercial officer was welcomed on board with commercial deal on focus.
I guess we don’t have to worry or lose patience by short-term price movements.
Hope for the best!
Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly, page-185
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3733217 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |